These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30768128)

  • 1. Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation.
    Song G; Moreau M; Efremenko A; Lake BG; Wu H; Bruckner JV; White CA; Osimitz TG; Creek MR; Hinderliter PM; Clewell HJ; Yoon M
    Toxicol Sci; 2019 Jun; 169(2):365-379. PubMed ID: 30768128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans.
    Mallick P; Moreau M; Song G; Efremenko AY; Pendse SN; Creek MR; Osimitz TG; Hines RN; Hinderliter P; Clewell HJ; Lake BG; Yoon M
    Toxicol Sci; 2020 Jan; 173(1):86-99. PubMed ID: 31593217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
    Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
    Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids.
    Mallick P; Song G; Efremenko AY; Pendse SN; Creek MR; Osimitz TG; Hines RN; Hinderliter P; Clewell HJ; Lake BG; Yoon M; Moreau M
    Toxicol Sci; 2020 Aug; 176(2):460-469. PubMed ID: 32421774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential lymphatic versus portal vein uptake of the synthetic pyrethroids deltamethrin and cis-permethrin in rats.
    Higgins LG; Chatham LR; Tomczynski SL; MacLeod AK; Moreau M; Clewell HJ; Yoon M; Creek MR; Osimitz TG; Lake BG
    Toxicology; 2020 Oct; 443():152563. PubMed ID: 32805335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBPK modeling to support risk assessment of pyrethroid exposure in French pregnant women.
    Thépaut E; Bisson M; Brochot C; Personne S; Appenzeller BMR; Zaros C; Chardon K; Zeman F
    Environ Res; 2024 Jun; 251(Pt 1):118606. PubMed ID: 38460660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of deltamethrin kinetics and dosimetry in the maturing rat using a PBPK model.
    Tornero-Velez R; Mirfazaelian A; Kim KB; Anand SS; Kim HJ; Haines WT; Bruckner JV; Fisher JW
    Toxicol Appl Pharmacol; 2010 Apr; 244(2):208-17. PubMed ID: 20045431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmentally relevant mixing ratios in cumulative assessments: a study of the kinetics of pyrethroids and their ester cleavage metabolites in blood and brain; and the effect of a pyrethroid mixture on the motor activity of rats.
    Starr JM; Graham SE; Ross DG; Tornero-Velez R; Scollon EJ; Devito MJ; Crofton KM; Wolansky MJ; Hughes MF
    Toxicology; 2014 Jun; 320():15-24. PubMed ID: 24631210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat.
    Mirfazaelian A; Kim KB; Anand SS; Kim HJ; Tornero-Velez R; Bruckner JV; Fisher JW
    Toxicol Sci; 2006 Oct; 93(2):432-42. PubMed ID: 16831841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: role in age-dependent acute neurotoxicity.
    Anand SS; Kim KB; Padilla S; Muralidhara S; Kim HJ; Fisher JW; Bruckner JV
    Drug Metab Dispos; 2006 Mar; 34(3):389-97. PubMed ID: 16326812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model.
    Godin SJ; DeVito MJ; Hughes MF; Ross DG; Scollon EJ; Starr JM; Setzer RW; Conolly RB; Tornero-Velez R
    Toxicol Sci; 2010 Jun; 115(2):330-43. PubMed ID: 20200215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the cumulative human exposures to pyrethroids by combined multi-route PBPK models: Application to the French population.
    Quindroit P; Beaudouin R; Brochot C
    Toxicol Lett; 2019 Sep; 312():125-138. PubMed ID: 31077771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmentally relevant mixtures in cumulative assessments: an acute study of toxicokinetics and effects on motor activity in rats exposed to a mixture of pyrethroids.
    Starr JM; Scollon EJ; Hughes MF; Ross DG; Graham SE; Crofton KM; Wolansky MJ; Devito MJ; Tornero-Velez R
    Toxicol Sci; 2012 Dec; 130(2):309-18. PubMed ID: 22872056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicokinetics and tissue distribution of deltamethrin in adult Sprague-Dawley rats.
    Kim KB; Anand SS; Kim HJ; White CA; Bruckner JV
    Toxicol Sci; 2008 Feb; 101(2):197-205. PubMed ID: 18056584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmentally relevant pyrethroid mixtures: A study on the correlation of blood and brain concentrations of a mixture of pyrethroid insecticides to motor activity in the rat.
    Hughes MF; Ross DG; Starr JM; Scollon EJ; Wolansky MJ; Crofton KM; DeVito MJ
    Toxicology; 2016 Jun; 359-360():19-28. PubMed ID: 27330022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation.
    Yoon M; Clewell HJ
    Toxicol Res; 2016 Jan; 32(1):15-20. PubMed ID: 26977255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of metabolism of deltamethrin and
    Price RJ; Scott MP; Cantrill C; Higgins LG; Moreau M; Yoon M; Clewell HJ; Creek MR; Osimitz TG; Houston JB; Lake BG
    Xenobiotica; 2021 Jan; 51(1):40-50. PubMed ID: 32757971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics.
    Song L; Zhang Y; Jiang J; Ren S; Chen L; Liu D; Chen X; Hu P
    Clin Pharmacokinet; 2018 Oct; 57(10):1307-1323. PubMed ID: 29626326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Protein and Lipoprotein Binding of
    Sethi P; Bruckner JV; Mortuza TB; Cummings BS; Muralidhara S; White CA
    Drug Metab Dispos; 2019 Sep; 47(9):941-948. PubMed ID: 31248885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.